SCHEMBL1343574

SCHEMBL1343574

N#CC=Cc1ccccc1[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.56
SOS1 Q07889 1/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
MAOB P27338 1/20 0.51
LMNA P02545 3/20 0.48
RAB9A P51151 4/20 0.48
NPC1 O15118 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CYP19A1 P11511 2/20 0.48
KDM4E B2RXH2 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
ALDH1A1 P00352 5/20 0.47
ATM Q13315 2/20 0.47
HSP90AA1 P07900 1/20 0.47
HPGD P15428 1/20 0.46
BACE1 P56817 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1343573 1.00 MAPT (0.56) MAPTSOS1MEN1KMT2AMAOB
SCHEMBL27780521 1.00 MAPT (0.56) MAPTSOS1MEN1KMT2AMAOB
SCHEMBL28412847 0.87 SOS1 (0.48) MAPTSOS1MEN1KMT2AMAOB
SCHEMBL166523 0.84 MAPT (0.57) MAPTSOS1MEN1KMT2AMAOB
SCHEMBL446483 0.84 MAPT (0.57) MAPTSOS1MEN1KMT2AMAOB
SCHEMBL6786004 0.83 ERN1 (0.61) MAPTMEN1KMT2AMAOBLMNA
SCHEMBL11275399 0.83 TDP1 (0.55) MAPTSOS1MEN1KMT2ARAB9A
SCHEMBL6786002 0.83 ERN1 (0.61) MAPTMEN1KMT2AMAOBLMNA
SCHEMBL11275396 0.83 TDP1 (0.55) MAPTSOS1MEN1KMT2ARAB9A
SCHEMBL9978289 0.82 MAPT (0.69) MAPTSOS1MEN1KMT2AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2684874-B1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors CEPHALON INC (US) 2017-05-17 EP disclosed
EP-2822933-B1 CUCN-MEDIATED ONE POT PRODUCTION OF CINNAMONITRILE DERIVATIVES COUNCIL SCIENT IND RES (IN) 2016-12-28 EP disclosed
EP-2222647-B1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS CEPHALON INC (US) 2015-08-05 EP disclosed
US-9096498-B2 CuCN-mediated one pot production of cinnamonitrile derivatives COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-08-04 US disclosed
US-9096498-B2 CuCN-mediated one pot production of cinnamonitrile derivatives COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-08-04 US disclosed
US-20150031899-A1 CUCN-MEDIATED ONE POT PRODUCTION OF CINNAMONITRILE DERIVATIVES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-01-29 US disclosed
US-20150031899-A1 CUCN-MEDIATED ONE POT PRODUCTION OF CINNAMONITRILE DERIVATIVES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-01-29 US disclosed
EP-2822933-A1 CUCN-MEDIATED ONE POT PRODUCTION OF CINNAMONITRILE DERIVATIVES Council of Scientific & Industrial Research (IN) 2015-01-14 EP disclosed
EP-2684874-A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors Cephalon, Inc. (US) 2014-01-15 EP disclosed
US-8552186-B2 Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors CEPHALON, INC. (US) 2013-10-08 US disclosed
US-20090137191-A1 COPPER CMP POLISHING PAD CLEANING COMPOSITION COMPRISING OF AMIDOXIME COMPOUNDS EKC TECHNOLOGY, INC. 2009-05-28 US disclosed
US-20090130849-A1 CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING COMPOSITION COMPRISING AMIDOXIME COMPOUNDS AND ASSOCIATED METHOD FOR USE EKC TECHNOLOGY, INC. 2009-05-21 US disclosed
WO-2009058274-A1 CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING COMPOSITION COMPRISING AMIDOXIME COMPOUNDS AND ASSOCIATED METHOD FOR USE EKC TECHNOLOGY, INC. (US) 2009-05-07 WO disclosed
WO-2009058278-A1 METHODS OF CLEANING SEMICONDUCTOR DEVICES AT THE BACK END OF LINE USING AMIDOXIME COMPOSITIONS EKC TECHNOLOGY, INC (US) 2009-05-07 WO disclosed
WO-2009058288-A1 AMIDOXIME COMPOUNDS AS CHELATING AGENTS IN SEMICONDUCTOR PROCESSES EKC TECHNOLOGY, INC. (US) 2009-05-07 WO disclosed
WO-2009058275-A1 METHODS OF POST CHEMICAL MECHANICAL POLISHING AND WAFER CLEANING USING AMIDOXIME COMPOSITIONS EKC TECHNOLOGY, INC. (US) 2009-05-07 WO disclosed
WO-2009058272-A1 COPPER CMP POLISHING PAD CLEANING COMPOSITION COMPRISING OF AMIDOXIME COMPOUNDS EKC TECHNOLOGY, INC. (US) 2009-05-07 WO disclosed
US-20090107520-A1 AMIDOXIME COMPOUNDS AS CHELATING AGENTS IN SEMICONDUCTOR PROCESSES EKC TECHNOLOGY, INC. 2009-04-30 US disclosed
WO-2008051547-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS CEPHALON, INC. (US) 2008-05-02 WO disclosed
US-4012377-A ANTIMICROBIAL, PARASITICIDES GLAXO LABORATORIES LIMITED (EN) 1977-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150031899-A1 CUCN-MEDIATED ONE POT PRODUCTION OF CINNAMONITRILE DERIVATIVES NISCH, PNN, NCLN MAPT 4152/4885SOS1 1717/4885MEN1 87/4885
US-20090137191-A1 COPPER CMP POLISHING PAD CLEANING COMPOSITION COMPRISING OF AMIDOXIME COMPOUNDS PADI2, PADI4, PADI3 MAPT 4191/4885SOS1 2494/4885MEN1 1915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.